US 12,268,697 B2
Oxysterols and methods of use thereof
Francesco G. Salituro, Marlborough, MA (US); Albert Jean Robichaud, Boston, MA (US); and Gabriel Martinez Botella, Wayland, MA (US)
Assigned to Sage Therapeutics, Inc., Cambridge, MA (US)
Filed by Sage Therapeutics, Inc., Cambridge, MA (US)
Filed on Mar. 13, 2024, as Appl. No. 18/603,816.
Application 18/603,816 is a continuation of application No. 16/942,245, filed on Jul. 29, 2020.
Application 16/942,245 is a continuation of application No. 16/227,099, filed on Dec. 20, 2018, granted, now 10,765,685, issued on Sep. 8, 2020.
Application 16/227,099 is a continuation of application No. 15/742,425, granted, now 10,201,550, issued on Feb. 12, 2019, previously published as PCT/US2016/041168, filed on Jul. 6, 2016.
Claims priority of provisional application 62/280,394, filed on Jan. 19, 2016.
Claims priority of provisional application 62/189,048, filed on Jul. 6, 2015.
Prior Publication US 2024/0277733 A1, Aug. 22, 2024
Int. Cl. A61K 31/575 (2006.01); C07J 9/00 (2006.01); C07J 7/00 (2006.01)
CPC A61K 31/575 (2013.01) [C07J 9/00 (2013.01); C07J 7/002 (2013.01); C07J 9/005 (2013.01)] 4 Claims
 
1. A compound having the structure

OG Complex Work Unit Chemistry